These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988 [TBL] [Abstract][Full Text] [Related]
6. Clinical use of beta-blockers in patients with heart failure. Eichhorn EJ J Card Fail; 2000 Jun; 6(2 Suppl 1):40-6. PubMed ID: 10908097 [TBL] [Abstract][Full Text] [Related]
7. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: modification by beta receptor blockers--a therapeutic approach?]. Lohmann FW Herz; 1990 Jun; 15(3):202-6. PubMed ID: 1973915 [TBL] [Abstract][Full Text] [Related]
8. Modulation of functional capacity and survival in congestive heart failure. Effects of activation of the sympathetic nervous system. Packer M Postgrad Med; 1988 Feb; Spec No():96-103. PubMed ID: 2894667 [TBL] [Abstract][Full Text] [Related]
9. [Critical analysis of beta blockers in heart failure: certainty and incompleteness]. Rapezzi C; Branzi A Ital Heart J Suppl; 2000 Aug; 1(8):1003-10. PubMed ID: 10993006 [TBL] [Abstract][Full Text] [Related]
10. The cellular and physiologic effects of beta blockers in heart failure. Sabbah HN Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699 [TBL] [Abstract][Full Text] [Related]
11. Beta-blockers: a new therapy in congestive heart failure. Meghani SH; Becker D Am J Crit Care; 2001 Nov; 10(6):417-27; quiz 428-9. PubMed ID: 11688609 [TBL] [Abstract][Full Text] [Related]
12. Beta-adrenergic receptor blockers as therapy in pediatric chronic heart failure. Shaddy RE Minerva Pediatr; 2001 Aug; 53(4):297-304. PubMed ID: 11573066 [TBL] [Abstract][Full Text] [Related]
13. [Elderly heart failure patients and the role of beta-blocker therapy]. Middeljans-Tijssen CW; Jansen RW Tijdschr Gerontol Geriatr; 2006 Apr; 37(2):67-77. PubMed ID: 16704019 [TBL] [Abstract][Full Text] [Related]
14. Mechanistic and clinical rationales for using beta-blockers in heart failure. Bristow MR J Card Fail; 2000 Jun; 6(2 Suppl 1):8-14. PubMed ID: 10908093 [TBL] [Abstract][Full Text] [Related]
15. Beta-adrenergic blocking drugs in severe heart failure. Fowler M Rev Cardiovasc Med; 2002; 3 Suppl 3():S20-6. PubMed ID: 12447158 [TBL] [Abstract][Full Text] [Related]
16. The sympathetic nervous system and pathophysiology of congestive heart failure. Farmer J Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):6-11. PubMed ID: 19667705 [TBL] [Abstract][Full Text] [Related]
17. Effects of ACE-inhibitors and beta-blockers on left ventricular remodeling in chronic heart failure. Khattar RS Minerva Cardioangiol; 2003 Apr; 51(2):143-54. PubMed ID: 12783070 [TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of the central nervous system beta-adrenoceptor blockade on the failing heart. Gourine A; Bondar SI; Spyer KM; Gourine AV Circ Res; 2008 Mar; 102(6):633-6. PubMed ID: 18323523 [TBL] [Abstract][Full Text] [Related]
20. Age is not a significant risk factor for failed trial of beta-blocker therapy in older patients with chronic heart failure. Witham MD; Gillespie ND; Struthers AD Age Ageing; 2004 Sep; 33(5):467-72. PubMed ID: 15217777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]